Position in ABBV
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$1,213,408
-$182,660 QoQ
Shares Held
4,822
-24.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.46%
of 13F equity value
Holder Rank
#2,368
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CALTON & ASSOCIATES, INC. holds $9,328,876 across 9 Drug Manufacturers - General names. ABBV ranks #4 (13.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,827 | $3,390,788 | |
| 2 | JNJ |
Johnson & Johnson
|
6,320 | $1,605,090 | |
| 3 | MRK |
Merck & Co., Inc.
|
9,693 | $1,245,550 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
4,822 | $1,213,408 | |
| 5 | PFE |
Pfizer Inc
|
26,875 | $647,150 | |
| 6 | AMGN |
Amgen Inc
|
1,111 | $402,315 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
5,244 | $302,159 | |
| 8 | GSK |
GSK plc
|
5,418 | $284,011 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,213,408 | 4,822 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $1,396,068 | 6,419 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,651,982 | 7,230 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $1,632,588 | 7,051 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $1,087,176 | 5,857 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,293,995 | 6,176 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $632,789 | 3,561 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $870,491 | 4,408 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $618,158 | 3,604 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $726,032 | 3,987 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $769,581 | 4,966 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $383,531 | 2,573 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $655,326 | 4,864 | Shares | Sole | 2023-07-24 | |
| 2023-03-31 | $786,172 | 4,933 | Shares | Sole | 2023-04-19 | |
| 2022-12-31 | $787,363 | 4,872 | Shares | Sole | 2023-01-18 | |
| 2022-09-30 | $562,474 | 4,191 | Shares | Sole | 2022-10-31 | |
| 2022-06-30 | $680,336 | 4,442 | Shares | Sole | 2022-07-12 | |
| 2022-03-31 | $903,601 | 5,574 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $844,760 | 6,239 | Shares | Sole | 2022-01-13 | |
| 2021-09-30 | $951,197 | 8,818 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $1,080,668 | 9,594 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $1,140,422 | 10,538 | Shares | Sole | 2021-05-03 | |
| 2020-12-31 | $2,093,282 | 19,536 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 | $2,200,698 | 25,125 | Shares | Sole | 2020-10-30 | |
| 2020-06-30 | $2,307,426 | 23,502 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $747,728 | 9,814 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||